pentoxifylline has been researched along with Primary Peritonitis in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the role of pentoxifylline as an adjuvant to operation and routine antibiotic treatment for perforated peritonitis." | 9.09 | Pentoxifylline in perforated peritonitis: results of a randomised, placebo controlled trial. ( Ojha, AK; Pandey, BL; Pandey, M; Shukla, VK, 2001) |
| "In cirrhotic rats with ascites: (a) pentoxifylline as well as norfloxacin reduced intestinal bacterial overgrowth and bacterial translocation and prevented spontaneous bacterial peritonitis; (b) pentoxifylline, but not norfloxacin, reduced oxidative stress in cecal mucosal." | 7.78 | Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites. ( Acevedo, J; Brusasco, C; Corradi, F; Fernández, J; Fernández-Varo, G; Gines, P; Mosbah, IB; Navasa, M; Pelosi, P; Ramirez, MJ; Rocco, PR; Seva-Pereira, T; Silva, A; Vila, J, 2012) |
| "The influence and relation between pentoxifylline (PTX) dose and time of administration and mortality rate of animals with experimental peritonitis (EP) were studied." | 7.72 | [The influence of pentoxifylline on the course of experimental peritonitis]. ( Czarnecki, P; Markert, R; Modzelewski, B, 2004) |
| "The aim of this study was to determine the effects of nimesulide and pentoxifylline on the contractile effects of KCl, carbachol and substance P in the longitudinal muscle of rat ileum during peritonitis." | 7.71 | Effects of nimesulide and pentoxifylline on decreased contractile responses in rat ileum with peritonitis. ( Arpacik, M; Karadas, B; Kaya, TT; Koyluoglu, G; Soydan, AS, 2002) |
| " An animal model of peritonitis was used to evaluate the effect of pentoxifylline." | 7.69 | Pentoxifylline improves intracellular electrolytes in sepsis. ( Boston, VE; Refsum, SE; Rowlands, BJ, 1994) |
| "We investigated pentoxifylline (PTF) as a pretreatment of septic syndrome in pigs with fecal peritonitis." | 7.68 | Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. ( al-Saady, N; Bennett, ED; Boghossian, S; Heath, MF; Hynd, J; Moss, R; Tighe, D, 1990) |
| " Those in the first group were sham operated, and those in the second and third groups underwent peritonitis induction; those in the latter group were treated with pentoxifylline (PTF)." | 7.67 | Pentoxifylline reduces pulmonary leucostasis and improves capillary patency in a rabbit peritonitis model. ( Bennett, ED; Heath, MF; Hynd, J; Moss, R; Tighe, D, 1989) |
| "The objective of this study was to determine the effect of pentoxifylline on the clinical and pathologic course of experimentally induced peritonitis in rats." | 7.67 | Pentoxifylline in the treatment of experimental peritonitis in rats. ( Chalkiadakis, GE; Chalkiadakis, ME; Giamarellou, H; Karayannacos, PE; Kostakis, A; Sgouromali, S; Skalkeas, GD, 1985) |
| "To evaluate the role of pentoxifylline as an adjuvant to operation and routine antibiotic treatment for perforated peritonitis." | 5.09 | Pentoxifylline in perforated peritonitis: results of a randomised, placebo controlled trial. ( Ojha, AK; Pandey, BL; Pandey, M; Shukla, VK, 2001) |
| "In cirrhotic rats with ascites: (a) pentoxifylline as well as norfloxacin reduced intestinal bacterial overgrowth and bacterial translocation and prevented spontaneous bacterial peritonitis; (b) pentoxifylline, but not norfloxacin, reduced oxidative stress in cecal mucosal." | 3.78 | Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites. ( Acevedo, J; Brusasco, C; Corradi, F; Fernández, J; Fernández-Varo, G; Gines, P; Mosbah, IB; Navasa, M; Pelosi, P; Ramirez, MJ; Rocco, PR; Seva-Pereira, T; Silva, A; Vila, J, 2012) |
| "The influence and relation between pentoxifylline (PTX) dose and time of administration and mortality rate of animals with experimental peritonitis (EP) were studied." | 3.72 | [The influence of pentoxifylline on the course of experimental peritonitis]. ( Czarnecki, P; Markert, R; Modzelewski, B, 2004) |
| "The aim of this study was to determine the effects of nimesulide and pentoxifylline on the contractile effects of KCl, carbachol and substance P in the longitudinal muscle of rat ileum during peritonitis." | 3.71 | Effects of nimesulide and pentoxifylline on decreased contractile responses in rat ileum with peritonitis. ( Arpacik, M; Karadas, B; Kaya, TT; Koyluoglu, G; Soydan, AS, 2002) |
| " The purpose of this study was to evaluate the ability of pentoxifylline to alter gut cytokine production in a rat model of prolonged acute peritonitis, to determine its effect on survival in such animals, and to determine whether alteration of gut cytokine production was associated with survival." | 3.70 | Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis. ( Alexander, JW; Mao, JX; Nelson, JL; Ogle, CK; Vohs, T, 1999) |
| " An animal model of peritonitis was used to evaluate the effect of pentoxifylline." | 3.69 | Pentoxifylline improves intracellular electrolytes in sepsis. ( Boston, VE; Refsum, SE; Rowlands, BJ, 1994) |
| "We investigated pentoxifylline (PTF) as a pretreatment of septic syndrome in pigs with fecal peritonitis." | 3.68 | Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. ( al-Saady, N; Bennett, ED; Boghossian, S; Heath, MF; Hynd, J; Moss, R; Tighe, D, 1990) |
| " Those in the first group were sham operated, and those in the second and third groups underwent peritonitis induction; those in the latter group were treated with pentoxifylline (PTF)." | 3.67 | Pentoxifylline reduces pulmonary leucostasis and improves capillary patency in a rabbit peritonitis model. ( Bennett, ED; Heath, MF; Hynd, J; Moss, R; Tighe, D, 1989) |
| "The objective of this study was to determine the effect of pentoxifylline on the clinical and pathologic course of experimentally induced peritonitis in rats." | 3.67 | Pentoxifylline in the treatment of experimental peritonitis in rats. ( Chalkiadakis, GE; Chalkiadakis, ME; Giamarellou, H; Karayannacos, PE; Kostakis, A; Sgouromali, S; Skalkeas, GD, 1985) |
| "Valproic acid (VA) is a major antiepileptic drug, used for several therapeutic indications." | 1.39 | Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties. ( Correia, AO; da Graça Naffah-Mazzacorati, M; de Castro Brito, GA; de Oliveira Gonçalves, D; Félix, FH; Leal, LK; Neves, KR; Santos Cerqueira, G; Siqueira, RM; Viana, GS; Ximenes, JC, 2013) |
| "The problem of sepsis and septic shock (SSH) is known to be very actual due to peak-shaped growth of the number of such patients and unsatisfactory results of treatment." | 1.32 | [Septic shock]. ( Bagnenko, SF; Grinev, MV; Gromov, MI; Kulibaba, DM, 2004) |
| "Diffuse peritonitis was elicited by means of cecal ligation and puncture (CLP) in 45 adult Wistar rats." | 1.32 | Pentoxyphilline as a cyclooxygenase (cox-2) inhibitor in experimental sepsis. ( Janiak, A; Modzelewski, B, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ximenes, JC | 1 |
| de Oliveira Gonçalves, D | 1 |
| Siqueira, RM | 1 |
| Neves, KR | 1 |
| Santos Cerqueira, G | 1 |
| Correia, AO | 1 |
| Félix, FH | 1 |
| Leal, LK | 1 |
| de Castro Brito, GA | 1 |
| da Graça Naffah-Mazzacorati, M | 1 |
| Viana, GS | 1 |
| Sireesh, I | 1 |
| Kaman, L | 1 |
| Singh, R | 1 |
| Corradi, F | 1 |
| Brusasco, C | 1 |
| Fernández, J | 1 |
| Vila, J | 1 |
| Ramirez, MJ | 1 |
| Seva-Pereira, T | 1 |
| Fernández-Varo, G | 1 |
| Mosbah, IB | 1 |
| Acevedo, J | 1 |
| Silva, A | 1 |
| Rocco, PR | 1 |
| Pelosi, P | 1 |
| Gines, P | 1 |
| Navasa, M | 1 |
| Grinev, MV | 1 |
| Bagnenko, SF | 1 |
| Kulibaba, DM | 1 |
| Gromov, MI | 1 |
| Modzelewski, B | 2 |
| Janiak, A | 1 |
| Czarnecki, P | 1 |
| Markert, R | 1 |
| Shevkhuzhev, ZA | 1 |
| Khanamatov, MKh | 1 |
| Refsum, SE | 4 |
| McCaigue, M | 2 |
| Campbell, GR | 1 |
| Barclay, GR | 1 |
| Erwin, PJ | 1 |
| Rowlands, BJ | 4 |
| Boston, VE | 4 |
| Halliday, MI | 2 |
| Norwood, W | 1 |
| Campbell, G | 1 |
| Quezado, ZM | 1 |
| Hoffman, WD | 1 |
| Banks, SM | 1 |
| Danner, RL | 1 |
| Eichacker, PQ | 1 |
| Susla, GM | 1 |
| Natanson, C | 1 |
| Fink, MP | 1 |
| Nelson, JL | 1 |
| Alexander, JW | 1 |
| Mao, JX | 1 |
| Vohs, T | 1 |
| Ogle, CK | 1 |
| Karimov, ShI | 1 |
| Babadzhanov, BD | 1 |
| Teshaev, OR | 1 |
| Beketov, GI | 1 |
| Kasymov, UK | 1 |
| Ruzmetov, PIu | 1 |
| Shukla, VK | 1 |
| Ojha, AK | 1 |
| Pandey, M | 1 |
| Pandey, BL | 1 |
| Kaya, TT | 1 |
| Koyluoglu, G | 1 |
| Soydan, AS | 1 |
| Arpacik, M | 1 |
| Karadas, B | 1 |
| Tighe, D | 3 |
| Moss, R | 3 |
| Hynd, J | 2 |
| Boghossian, S | 1 |
| al-Saady, N | 1 |
| Heath, MF | 3 |
| Bennett, ED | 3 |
| Chalkiadakis, GE | 1 |
| Kostakis, A | 1 |
| Karayannacos, PE | 1 |
| Chalkiadakis, ME | 1 |
| Sgouromali, S | 1 |
| Giamarellou, H | 1 |
| Skalkeas, GD | 1 |
2 trials available for pentoxifylline and Primary Peritonitis
| Article | Year |
|---|---|
Pentoxifylline as an adjuvant to surgery and antibiotics in the treatment of perforation peritonitis: a prospective, randomised placebo-controlled study.
Topics: Adjuvants, Pharmaceutic; Adult; Anti-Bacterial Agents; Combined Modality Therapy; Female; Humans; Ma | 2008 |
Pentoxifylline in perforated peritonitis: results of a randomised, placebo controlled trial.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; APACHE; Combined Modality Therapy; Double-Blind Method; F | 2001 |
19 other studies available for pentoxifylline and Primary Peritonitis
| Article | Year |
|---|---|
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Butyric Acid; Carrageenan; Drug Syne | 2013 |
Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Ascites; Ascitic Fluid; Bacterial Translocatio | 2012 |
[Septic shock].
Topics: Abdominal Injuries; Adjuvants, Immunologic; Anti-Bacterial Agents; Blood Transfusion; Enzyme Inhibit | 2004 |
Pentoxyphilline as a cyclooxygenase (cox-2) inhibitor in experimental sepsis.
Topics: Animals; Antigens, CD; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dis | 2004 |
[The influence of pentoxifylline on the course of experimental peritonitis].
Topics: Animals; Disease Models, Animal; Male; Pentoxifylline; Peritonitis; Phosphodiesterase Inhibitors; Ra | 2004 |
[Endolymphatic drug infusion in the treatment of complicated acute appendicitis].
Topics: Abscess; Acute Disease; Anti-Bacterial Agents; Appendicitis; Aprotinin; Aspirin; Cefotaxime; Ceftazi | 1993 |
Pentoxifylline modulates cytokine responses in a sepsis model.
Topics: Animals; Antibodies; Blood Pressure; Cytokines; Disease Models, Animal; Endotoxins; Female; Interleu | 1994 |
Pentoxifylline improves intracellular electrolytes in sepsis.
Topics: Animals; Chlorides; Electrolytes; Extracellular Space; Hyponatremia; Membrane Potentials; Muscles; P | 1994 |
Pentoxifylline improves resting membrane potential in sepsis.
Topics: Animals; Bacterial Infections; Drug Administration Schedule; Female; Membrane Potentials; Muscles; P | 1993 |
Modulation of TNF alpha and IL-6 in a peritonitis model using pentoxifylline.
Topics: Animals; Blood Pressure; Cecum; Disease Models, Animal; Female; Interleukin-6; Intestinal Perforatio | 1996 |
Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Body Temperature; Disease Models, Animal; Dogs | 1999 |
Whither pentoxifylline?
Topics: Animals; Bacteremia; Dose-Response Relationship, Drug; Pentoxifylline; Peritonitis; Phosphodiesteras | 1999 |
Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis.
Topics: Animals; Bacteremia; Critical Care; Cytokines; Dietary Proteins; Disease Models, Animal; Dose-Respon | 1999 |
[Role of prolonged intraarterial catheter therapy in general peritonitis].
Topics: Adult; Anti-Bacterial Agents; Aorta, Abdominal; Catheters, Indwelling; Dextrans; Drug Therapy, Combi | 2000 |
Effects of nimesulide and pentoxifylline on decreased contractile responses in rat ileum with peritonitis.
Topics: Animals; Carbachol; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; | 2002 |
Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model.
Topics: Animals; Hemodynamics; Liver; Lung; Models, Biological; Neutrophils; Pentoxifylline; Peritonitis; Sp | 1990 |
Relevance of serum phospholipase A2 assays to the assessment of septic shock.
Topics: Animals; Models, Biological; Pentoxifylline; Peritonitis; Phospholipases; Phospholipases A; Phosphol | 1990 |
Pentoxifylline reduces pulmonary leucostasis and improves capillary patency in a rabbit peritonitis model.
Topics: Animals; Capillaries; Endothelium; Epithelium; Leukocytes; Lung; Microscopy, Electron; Pentoxifyllin | 1989 |
Pentoxifylline in the treatment of experimental peritonitis in rats.
Topics: Abscess; Animals; Female; Male; Pentoxifylline; Peritonitis; Prognosis; Rats; Rats, Inbred Strains; | 1985 |